The second-quarter earnings season is over for all intents and purposesIt was the second quarter in a row that the S&P 500 saw more than 20% year-over-year profit growthIn today's column we will look at some small biotech and biopharma names that are seeing huge revenue growth as they continue on their path to eventual profitabilityWe will start w...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.